Cerivastatin (brand names: Baycol Lipobay) is a synthetic member of the class of statins used to lower cholesterol and prevent cardiovascular disease. It was marketed by the pharmaceutical company Bayer A.G. in the late 1990s competing with Pfizer’s highly successful atorvastatin (Lipitor).
This page contains content from the copyrighted Wikipedia article "Cerivastatin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
